BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 429024)

  • 1. Effects of anticholinesterase agents on some isoprenaline induced changes in rat heart.
    Das PK; Dube SN
    Indian J Med Res; 1979 Jan; 69():189-94. PubMed ID: 429024
    [No Abstract]   [Full Text] [Related]  

  • 2. The interaction between some anticholinesterase drugs and atropine on the pentobarbital sleeping time in the rat.
    Kayaalp SO; Numanoğlu S
    Arch Int Pharmacodyn Ther; 1965 Dec; 158(2):403-10. PubMed ID: 5868590
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of some cholinolytics and anticholinesterase agents on the frog electroolfactogram].
    Kruzhalov NB; Gusel'nikova KG
    Fiziol Zh SSSR Im I M Sechenova; 1971 Nov; 57(11):1740-2. PubMed ID: 5158563
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of physostigmine and neostigmine on the concentration of glycogen in diaphragm and triceps muscle of the rat.
    Mrsulja BB; Terzić M; Varagić VM
    Biochem Pharmacol; 1970 Jun; 19(6):2125-30. PubMed ID: 5513978
    [No Abstract]   [Full Text] [Related]  

  • 5. The mechanism of action of physostigmine at muscarinic receptors of rat myocardium.
    Orsetti M
    Boll Soc Ital Biol Sper; 1986 Jan; 62(1):67-73. PubMed ID: 3718728
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of cholinesterase inhibitors on the susceptibility to pentetrazole of the mouse.
    György L; Döda M
    Acta Physiol Acad Sci Hung; 1974; 45(3-4):243-51. PubMed ID: 4471270
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of oximes on the acute toxicity of anticholinesterase carbamates.
    Natoff IL; Reiff B
    Toxicol Appl Pharmacol; 1973 Aug; 25(4):569-75. PubMed ID: 4741778
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of physostigmine and neostigmine on the glycogen stores in the heart and in the adrenals.
    Mrsulja BB; Varagić VM
    Biochem Pharmacol; 1971 Jun; 20(6):1191-9. PubMed ID: 5118117
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of the potencies of edrophonium, neostigmine and eserine with a new anticholinesterase drug RX 67668 on human tissues.
    Turner P; Variava DM
    Br J Pharmacol; 1973 Mar; 47(3):678P. PubMed ID: 4730883
    [No Abstract]   [Full Text] [Related]  

  • 10. Mobilization of cellular choline by stimulation of muscarine receptors in isolated chicken heart and rat cortex in vivo.
    Corradetti R; Lindmar R; Löffelholz K
    J Pharmacol Exp Ther; 1983 Sep; 226(3):826-32. PubMed ID: 6887013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Actions of anticholinesterase agents upon ganglionic transmission in the dog.
    Gillis RA; Flacke W; Garfield JM; Alper MH
    J Pharmacol Exp Ther; 1968 Oct; 163(2):277-86. PubMed ID: 4300677
    [No Abstract]   [Full Text] [Related]  

  • 12. Cholinergic modulation of intrinsic fibre-evoked excitatory transmission contains a nicotinic component in immature but not adult rat piriform cortex, in vitro.
    Patel NA; Weston SE; Constanti A; Halliwell JV; Whalley BJ
    Neurosci Lett; 2007 Sep; 425(1):43-8. PubMed ID: 17723269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation and blockade of cardiac muscarinic receptors by endogenous acetylcholine and cholinesterase inhibitors.
    Brown JH; Wetzel GT; Dunlap J
    J Pharmacol Exp Ther; 1982 Oct; 223(1):20-4. PubMed ID: 6288918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibition of frog tissue cholinesterases and the influence of eserine and prostigmine on the action of acetylcholine on the frog heart.
    Majcen Z; Brzin M
    Biochem Pharmacol; 1975 Sep; 24(17):1599-602. PubMed ID: 1081394
    [No Abstract]   [Full Text] [Related]  

  • 15. A test for the assessment of the duration of the action of neostigmine and of the relative potencies of various anticholinesterases using the pupil of the mouse.
    Schneider R
    J Pharm Pharmacol; 1970 Apr; 22(4):298-301. PubMed ID: 4392572
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanisms of cardiac muscle insensitivity to a novel acetylcholinesterase inhibitor C-547.
    Abramochkin DV; Petrov KA; Zobov VV; Yagodina LO; Nikolsky EE; Rosenshtraukh LV
    J Cardiovasc Pharmacol; 2009 Feb; 53(2):162-6. PubMed ID: 19188831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketamine antagonizes toxic action of anticholinesterase agents.
    Contreras CM; Marvan ML; Mexicano G; Puente A; Morfin A
    Bol Estud Med Biol; 1990; 38(1-2):10-5. PubMed ID: 2291776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal by atropine of tetanic fade induced in cats by antinicotinic and anticholinesterase agents.
    Alves-do-Prado W; Corrado AP; Prado WA
    Anesth Analg; 1987 Jun; 66(6):492-6. PubMed ID: 2883915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of anticholinesterase activity and the effectiveness of anticholinesterase substances].
    Prozorovskĭ VB; Artem'ev VS; Tonkopiĭ VD; Konstorum MG
    Farmakol Toksikol; 1975; 38(4):402-6. PubMed ID: 1213123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A heat-stressed rat model to determine relative anticholinergic and anticholinesterase drug potency.
    Matthew CB; Hubbard RW; Francesconi RP
    Aviat Space Environ Med; 1986 Nov; 57(11):1061-5. PubMed ID: 3790025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.